Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Bafna Pharmaceuticals Statistics

Total Valuation

NSE:BAFNAPH has a market cap or net worth of INR 3.28 billion. The enterprise value is 3.63 billion.

Market Cap	3.28B
Enterprise Value	3.63B

Important Dates

The last earnings date was Friday, May 29, 2026.

Earnings Date	May 29, 2026
Ex-Dividend Date	n/a

Share Statistics

NSE:BAFNAPH has 23.66 million shares outstanding. The number of shares has increased by 0.05% in one year.

Current Share Class	23.66M
Shares Outstanding	23.66M
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	4.97%
Owned by Institutions (%)	4.36%
Float	3.34M

Valuation Ratios

The trailing PE ratio is 29.53.

PE Ratio	29.53
Forward PE	n/a
PS Ratio	2.11
PB Ratio	3.41
P/TBV Ratio	3.41
P/FCF Ratio	n/a
P/OCF Ratio	21.31
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.53, with an EV/FCF ratio of -38.08.

EV / Earnings	32.71
EV / Sales	2.34
EV / EBITDA	17.53
EV / EBIT	24.81
EV / FCF	-38.08

Financial Position

The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.39.

Current Ratio	1.57
Quick Ratio	0.81
Debt / Equity	0.39
Debt / EBITDA	1.81
Debt / FCF	-3.93
Interest Coverage	4.00

Financial Efficiency

Return on equity (ROE) is 12.27% and return on invested capital (ROIC) is 11.48%.

Return on Equity (ROE)	12.27%
Return on Assets (ROA)	5.57%
Return on Invested Capital (ROIC)	11.48%
Return on Capital Employed (ROCE)	12.36%
Weighted Average Cost of Capital (WACC)	5.49%
Revenue Per Employee	3.83M
Profits Per Employee	273,394
Employee Count	406
Asset Turnover	0.95
Inventory Turnover	3.60

Taxes

Income Tax	-1.30M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +74.63% in the last 52 weeks. The beta is 0.18, so NSE:BAFNAPH's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	+74.63%
50-Day Moving Average	127.87
200-Day Moving Average	132.26
Relative Strength Index (RSI)	49.05
Average Volume (20 Days)	2,381

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:BAFNAPH had revenue of INR 1.55 billion and earned 111.00 million in profits. Earnings per share was 4.69.

Revenue	1.55B
Gross Profit	528.90M
Operating Income	146.31M
Pretax Income	109.70M
Net Income	111.00M
EBITDA	207.04M
EBIT	146.31M
Earnings Per Share (EPS)	4.69

Balance Sheet

The company has 20.25 million in cash and 374.33 million in debt, with a net cash position of -354.09 million or -14.97 per share.

Cash & Cash Equivalents	20.25M
Total Debt	374.33M
Net Cash	-354.09M
Net Cash Per Share	-14.97
Equity (Book Value)	961.50M
Book Value Per Share	40.57
Working Capital	324.63M

Cash Flow

In the last 12 months, operating cash flow was 153.71 million and capital expenditures -249.03 million, giving a free cash flow of -95.32 million.

Operating Cash Flow	153.71M
Capital Expenditures	-249.03M
Depreciation & Amortization	60.73M
Net Borrowing	92.35M
Free Cash Flow	-95.32M
FCF Per Share	-4.03

Margins

Gross margin is 34.04%, with operating and profit margins of 9.42% and 7.14%.

Gross Margin	34.04%
Operating Margin	9.42%
Pretax Margin	7.06%
Profit Margin	7.14%
EBITDA Margin	13.33%
EBIT Margin	9.42%
FCF Margin	n/a

Dividends & Yields

NSE:BAFNAPH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.05%
Shareholder Yield	-0.05%
Earnings Yield	3.39%
FCF Yield	-2.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5